NCT06399575

Brief Summary

Apneas (breath-holds) are increasingly being tested in human subjects to understand how the human body operates. Apneas decrease heart rate and increase blood pressure. These findings are driving current research into the effects of oxygen concentrations on the heart rate and blood pressure responses to apneas and the effect of breath-hold training on these responses. The interest in apnea research is three-fold:

  1. 1.Apneas are a nervous system stressor that can help researchers better understand the fundamental operation of the human body;
  2. 2.Elite divers can use findings from research to better their training and performance; and
  3. 3.The scientific understanding of apneas may translate to a better understanding of sleep apnea.
  4. 4.To provide greater certainty to previous results; and
  5. 5.Inform best practices for future studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

May 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2024

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

2 months

First QC Date

April 21, 2024

Last Update Submit

July 1, 2024

Conditions

Keywords

RepeatabilityReproducibilityHeart Rate

Outcome Measures

Primary Outcomes (1)

  • Heart Rate

    Electrocardiogram (lead II)

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before each apnea) and during apneas (beat-by-beat extraction from the 10 beats preceding resumption of breathing).

Secondary Outcomes (5)

  • Blood Pressure

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before each apnea) and during apneas (beat-by-beat extraction from the 10 beats preceding resumption of breathing).

  • Cardiac Arrhythmias

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during apneas (beat-by-beat observation from the 10 beats preceding the resumption of breathing).

  • Peripheral Oxygen Saturation

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before each apnea) and during apneas (10 beats preceding the resumption of breathing to 1 minute after apnea end).

  • Rating of Perceived Exertion

    Apnea (immediately following apnea)

  • Apnea Duration

    Start to end of apnea: apnea start determined using cessation of flow through the pneumotachometer, apnea end determined using respiratory belt strain gauge. Estimated apnea durations are 15-30 seconds.

Other Outcomes (3)

  • End-Tidal Oxygen

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before apnea).

  • End-Tidal Carbon Dioxide

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before apnea).

  • Minute Ventilation

    Continuous collection during both visits (2 hours on back-to-back days). Data will be extracted during free breathing (1 minute average before apnea).

Study Arms (1)

Apnea Following Isocapnic Hypoxia

EXPERIMENTAL
Other: Apnea Following Isocapnic Hypoxia

Interventions

Decreasing end-tidal partial pressure of oxygen to 50 mmHg for five minutes, targeting 80-85% peripheral oxygen saturation. The end-tidal partial pressure of carbon dioxide will remain +1 mmHg above baseline levels. After five minutes of hypoxia, participants will complete an apnea.

Apnea Following Isocapnic Hypoxia

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females between the ages of 18-70

You may not qualify if:

  • Having known cardiovascular or nervous system disease
  • Low or high blood pressure (\< 90/60 or \>139/85, respectively)
  • Taking any prescribed medications (other than oral contraceptives) that may affect cardiovascular system function
  • Females who may be pregnant (self-reported)
  • Involved in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G 2E1, Canada

Location

Related Publications (5)

  • Busch SA, Davies H, van Diepen S, Simpson LL, Sobierajski F, Riske L, Stembridge M, Ainslie PN, Willie CK, Hoiland R, Moore JP, Steinback CD. Chemoreflex mediated arrhythmia during apnea at 5,050 m in low- but not high-altitude natives. J Appl Physiol (1985). 2018 Apr 1;124(4):930-937. doi: 10.1152/japplphysiol.00774.2017. Epub 2017 Dec 21.

    PMID: 29357505BACKGROUND
  • Busch SA, van Diepen S, Steele AR, Meah VL, Simpson LL, Figueroa-Mujica RJ, Vizcardo-Galindo G, Villafuerte FC, Tymko MM, Ainslie PN, Moore JP, Stembridge M, Steinback CD. Global REACH: Assessment of Brady-Arrhythmias in Andeans and Lowlanders During Apnea at 4330 m. Front Physiol. 2020 Jan 22;10:1603. doi: 10.3389/fphys.2019.01603. eCollection 2019.

    PMID: 32038287BACKGROUND
  • Stanforth PR, Gagnon J, Rice T, Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH. Reproducibility of resting blood pressure and heart rate measurements. The HERITAGE Family Study. Ann Epidemiol. 2000 Jul;10(5):271-7. doi: 10.1016/s1047-2797(00)00047-8.

    PMID: 10942874BACKGROUND
  • Hopkins WG. Measures of reliability in sports medicine and science. Sports Med. 2000 Jul;30(1):1-15. doi: 10.2165/00007256-200030010-00001.

    PMID: 10907753BACKGROUND
  • Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005 Feb;19(1):231-40. doi: 10.1519/15184.1.

    PMID: 15705040BACKGROUND

MeSH Terms

Conditions

HypoxiaApnea

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2024

First Posted

May 6, 2024

Study Start

May 2, 2024

Primary Completion

June 28, 2024

Study Completion

June 28, 2024

Last Updated

July 3, 2024

Record last verified: 2024-07

Locations